Common Names
Geographic Range: Native to Andean cloud forests (Peru, Ecuador, Colombia, Bolivia) at 1500-3000m elevation. Historically cultivated in Java, India, Sri Lanka, and East Africa.
Known Contraindications
1
Compounds
2
Traditions
2
Treatments
1
Conditions
COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C4=C)c2c1CYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| CYP1A2 | weak substrate |
| CYP2D6 | moderate inhibitor |
| CYP3A4 | primary substrate and moderate inhibitor |
| clinical_note | CYP3A4 and CYP2D6 inhibition — significant drug interactions with digoxin, warfarin, mefloquine. QT prolongation risk with other QT-prolonging drugs. Narrow therapeutic index. |